117 related articles for article (PubMed ID: 35313793)
21. Synthesis of IFN-gamma by CD8(+) T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions.
Lee BN; Follen M; Tortolero-Luna G; Eriksen N; Helfgott A; Hammill H; Shearer WT; Reuben JM
Gynecol Oncol; 1999 Dec; 75(3):379-86. PubMed ID: 10600293
[TBL] [Abstract][Full Text] [Related]
22. Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia.
Passmore JA; Marais DJ; Sampson C; Allan B; Parker N; Milner M; Denny L; Williamson AL
J Med Virol; 2007 Sep; 79(9):1375-80. PubMed ID: 17607771
[TBL] [Abstract][Full Text] [Related]
23. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results.
Bodner K; Bodner-Adler B; Wierrani F; Kubin A; Szölts-Szölts J; Spängler B; Grünberger W
Anticancer Res; 2003; 23(2C):1785-8. PubMed ID: 12820459
[TBL] [Abstract][Full Text] [Related]
24. Association of human leukocyte antigen and T cell message with human papillomavirus 16-positive cervical neoplasia in Japanese women.
Saito M; Okubo M; Hirata R; Takeda S; Maeda H
Int J Gynecol Cancer; 2007; 17(6):1314-21. PubMed ID: 17433060
[TBL] [Abstract][Full Text] [Related]
25. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
Wang R; Li X; Qian M; Niu J; You Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
[TBL] [Abstract][Full Text] [Related]
26. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
Kadish AS; Ho GY; Burk RD; Wang Y; Romney SL; Ledwidge R; Angeletti RH
J Natl Cancer Inst; 1997 Sep; 89(17):1285-93. PubMed ID: 9293919
[TBL] [Abstract][Full Text] [Related]
27. Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure.
Cecchini S; Carozzi F; Confortini M; Zappa M; Ciatto S
Tumori; 2004; 90(2):225-8. PubMed ID: 15237586
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of cold coagulation in treating high-grade cervical intraepithelial neoplasia: the human papillomavirus evidence of cure.
Tadesse WG; Oni AAA; Hickey KPW
J Obstet Gynaecol; 2019 Oct; 39(7):965-968. PubMed ID: 31094247
[TBL] [Abstract][Full Text] [Related]
29. T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer.
Chan PK; Liu SJ; Cheung JL; Cheung TH; Yeo W; Chong P; Man S
J Med Virol; 2011 Jun; 83(6):1023-30. PubMed ID: 21503915
[TBL] [Abstract][Full Text] [Related]
30. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens.
Elfgren K; Bistoletti P; Dillner L; Walboomers JM; Meijer CJ; Dillner J
Am J Obstet Gynecol; 1996 Mar; 174(3):937-42. PubMed ID: 8633673
[TBL] [Abstract][Full Text] [Related]
31. Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia.
Kawahara R; Fujii T; Kukimoto I; Nomura H; Kawasaki R; Nishio E; Ichikawa R; Tsukamoto T; Iwata A
Sci Rep; 2021 Jan; 11(1):2156. PubMed ID: 33495564
[TBL] [Abstract][Full Text] [Related]
32. [Expressions of HLA class I antigen and CD8 and their clinical significance in cervical cancer].
Qi Y; Huang JS; Wang DD; Zhang F; Zhang SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2165-9. PubMed ID: 19114347
[TBL] [Abstract][Full Text] [Related]
33. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
34. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response.
Dong DD; Yang H; Li K; Xu G; Song LH; Fan XL; Jiang XL; Yie SM
Reprod Sci; 2010 Aug; 17(8):718-23. PubMed ID: 20445010
[TBL] [Abstract][Full Text] [Related]
35. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.
Bais AG; Beckmann I; Lindemans J; Ewing PC; Meijer CJ; Snijders PJ; Helmerhorst TJ
J Clin Pathol; 2005 Oct; 58(10):1096-100. PubMed ID: 16189158
[TBL] [Abstract][Full Text] [Related]
36. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection.
Glew SS; Connor ME; Snijders PJ; Stanbridge CM; Buckley CH; Walboomers JM; Meijer CJ; Stern PL
Eur J Cancer; 1993; 29A(14):1963-70. PubMed ID: 8280490
[TBL] [Abstract][Full Text] [Related]
37. Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: A retrospective study of 118 patients.
Yu D; Qu P; Liu M
J Obstet Gynaecol Res; 2021 May; 47(5):1624-1630. PubMed ID: 33754436
[TBL] [Abstract][Full Text] [Related]
38. A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.
Muderspach L; Wilczynski S; Roman L; Bade L; Felix J; Small LA; Kast WM; Fascio G; Marty V; Weber J
Clin Cancer Res; 2000 Sep; 6(9):3406-16. PubMed ID: 10999722
[TBL] [Abstract][Full Text] [Related]
39. Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia.
Visser J; Nijman HW; Hoogenboom BN; Jager P; van Baarle D; Schuuring E; Abdulahad W; Miedema F; van der Zee AG; Daemen T
Clin Exp Immunol; 2007 Nov; 150(2):199-209. PubMed ID: 17937675
[TBL] [Abstract][Full Text] [Related]
40. Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy.
Brun JL; Dalstein V; Leveque J; Mathevet P; Raulic P; Baldauf JJ; Scholl S; Huynh B; Douvier S; Riethmuller D; Clavel C; Birembaut P; Calenda V; Baudin M; Bory JP
Am J Obstet Gynecol; 2011 Feb; 204(2):169.e1-8. PubMed ID: 21284968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
